Announcement on Progress in Repurchasing Shares
Filed with SSE · · 2 pages · Chinese
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- Announcement on Obtaining Registration Approval of Application for Issuing Convertible Corporate Bonds to Non-specific Objects from China Securities Regulatory Commission
- Announcement on Repurchasing 2% Shares through Call Auction and Progress in Repurchasing Shares
- Announcement on Voluntary Disclosure on the Acceptance Notification of Clinical Trial Application for ACT201 Injection
- Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
- Announcement on Initially Repurchasing Shares through Call Auction and Progress in Repurchasing
Later from Xiamen Amoytop Biotech
- Voluntary Disclosure Announcement on ACT201 Injection Obtaining Notice of Approval for Drug Clinical Trial
- Announcement on the Online Roadshow for the Issuance of Convertible Corporate Bonds to Unspecified Investors
- Indicative Announcement on Issuance of Convertible Corporate Bonds to Unspecified Investors
- Announcement on Online Subscription Success Rate and Priority Placement Results for the Public Offering of Convertible Bonds to Unspecified Investors
- Announcement on Online Balloting Results for the Public Offering of Convertible Corporate Bonds to Unspecified Investors
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech